4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000003
Chief Executive Officer sold 5,105 shares at $24.10 ($123,031)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Salzmann Peter Chief Executive Officer | 2025-01-08 | Sale | −5,105 | $24.10 | $123,031 | 972,992 | D |
| Open-market sales · 5,105 sh · avg $24.10 · $123,031 | |||||||
Loading xslF345X05/wk-form4_1736543457.xml…